SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice
Reference64 articles.
1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res. Clin. Pract.,2014
2. Screening for kidney disease in adults with diabetes;Kramer;Diabetes Care,2005
3. The economic consequences of diabetes and cardiovascular disease in the United States;Ariza;Rev. Endocr. Metab. Disord.,2010
4. Medical costs associated with type 2 diabetes complications and comorbidities;Li;Am. J. Manag. Care,2013
5. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain;Mata-Cases;Eur. J. Health Econ.,2016
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10
2. Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study);Indian Journal of Endocrinology and Metabolism;2024-03-08
3. Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study;Cardiovascular Diabetology;2024-02-08
4. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30
5. A systematic review of sodium-glucose cotransporter 2 inhibitors and renal profiles among Japanese patients with type 2 diabetes mellitus;Journal of Pharmaceutical Health Care and Sciences;2023-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3